Literature DB >> 15604543

Zileuton, an oral 5-lipoxygenase inhibitor, directly reduces sebum production.

Ch C Zouboulis1, A Saborowski, A Boschnakow.   

Abstract

BACKGROUND: Zileuton, a 5-lipoxygenase inhibitor, reduces the number of inflammatory lesions in moderate acne and inhibits the synthesis of sebaceous lipids.
OBJECTIVE: To detect whether zileuton directly reduces sebum synthesis.
METHODS: A 40-year-old female with mild disseminated sebaceous gland hyperplasia and seborrhea was treated with zileuton 4 x 600 mg/day over 2 weeks, was followed-up for 6 weeks after discontinuation of zileuton and was re-treated with low-dose isotretinoin 10 mg/2nd day over 5 weeks. Casual skin surface lipids and sebum synthesis were determined.
RESULTS: Under treatment with zileuton increased casual skin surface lipids were normalized and synthesis of facial sebum was decreased. Six weeks after discontinuation of treatment casual skin surface lipids were increased again and synthesis of sebum returned to baseline. Subsequent low-dose isotretinoin treatment led to similar changes of casual skin surface lipids and sebum synthesis with zileuton already after 2 weeks.
CONCLUSION: Zileuton directly inhibits sebum synthesis in a transient manner with a potency similar to low-dose isotretinoin at least in our patient.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15604543     DOI: 10.1159/000081481

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  14 in total

1.  The relationship of diet and acne: A review.

Authors:  Apostolos Pappas
Journal:  Dermatoendocrinol       Date:  2009-09

Review 2.  [Pathophysiology of acne].

Authors:  C Borelli; G Plewig; K Degitz
Journal:  Hautarzt       Date:  2005-11       Impact factor: 0.751

3.  Zileuton, a new efficient and safe systemic anti-acne drug.

Authors:  Christos C Zouboulis
Journal:  Dermatoendocrinol       Date:  2009-05

4.  Peroxisome proliferator-activated receptors (PPARs) in dermatology: Challenge and promise.

Authors:  Pit Sertznig; Jörg Reichrath
Journal:  Dermatoendocrinol       Date:  2011-07-01

Review 5.  Peroxisome proliferator-activated receptors and their ligands: entry into the post-glucocorticoid era of skin treatment?

Authors:  Günther Weindl; Monika Schäfer-Korting; Martin Schaller; Hans Christian Korting
Journal:  Drugs       Date:  2005       Impact factor: 9.546

6.  Enzymes involved in the biosynthesis of leukotriene B4 and prostaglandin E2 are active in sebaceous glands.

Authors:  Theodosios Alestas; Ruta Ganceviciene; Sabine Fimmel; Karin Müller-Decker; Christos C Zouboulis
Journal:  J Mol Med (Berl)       Date:  2005-12-31       Impact factor: 4.599

Review 7.  Lipid mediators in acne.

Authors:  Monica Ottaviani; Emanuela Camera; Mauro Picardo
Journal:  Mediators Inflamm       Date:  2010-08-25       Impact factor: 4.711

8.  [Acne vulgaris. The role of hormones].

Authors:  C C Zouboulis
Journal:  Hautarzt       Date:  2010-02       Impact factor: 0.751

9.  Discovery of a novel dual fungal CYP51/human 5-lipoxygenase inhibitor: implications for anti-fungal therapy.

Authors:  Eric K Hoobler; Ganesha Rai; Andrew G S Warrilow; Steven C Perry; Christopher J Smyrniotis; Ajit Jadhav; Anton Simeonov; Josie E Parker; Diane E Kelly; David J Maloney; S L Kelly; Theodore R Holman
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

10.  Acne vulgaris, mental health and omega-3 fatty acids: a report of cases.

Authors:  Mark G Rubin; Katherine Kim; Alan C Logan
Journal:  Lipids Health Dis       Date:  2008-10-13       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.